ENG/中
老虎證券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登入
立即註冊
Toggle
港股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
中醫藥概念
859.599
+0.312
0.04%
手動刷新
漲家數:
8
跌家數:
2
平家數:
1
市盈率:
- -
高:
864.663
開:
855.556
低:
851.314
收:
859.287
成交量:
5,007.15萬
成交額:
1.93億
市值:
873.30億
流通市值:
607.60億
資料載入中...
總覽
新聞資訊
白雲山:公司已聘請第三方機構探索制定薪酬績效優化方案
证券日报
·
04/03
白雲山:未來五年公司將堅持現代化、科技化、數字化、國際化發展方向
证券日报
·
04/03
中國中藥(00570)出現大手賣出110萬股,成交價$1.8,涉資198萬
阿斯达克财经
·
04/02
綠葉製藥(02186)出現大手賣出130萬股,成交價$2.92,涉資379.6萬
阿斯达克财经
·
04/02
白雲山(00874):白雲山製藥總廠獲國家藥監局核准簽發關於骨化三醇軟膠囊的《藥品補充申請批准通知書》
智通财经
·
04/01
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK1606/news?page=2"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1606","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1606\",,,,,undefined,":{"symbol":"BK1606","market":"HK","secType":"PLATE","nameCN":"中醫藥概念","latestPrice":859.5988,"timestamp":1776326890394,"preClose":859.2869,"halted":0,"volume":50071504,"delay":0,"changeRate":0.000363,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盤","change":0.31189,"latestTime":"04-16 16:00:00","open":855.5556,"high":864.6631,"low":851.3144,"amount":192892919,"amplitude":0.015535,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1776389400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1776303000000,1776312000000],[1776315600000,1776326400000]],"pbRate":0.863325,"peRate":14.021183,"turnoverRate":0.003165,"increases":7,"decrements":2,"flats":2,"marketCap":87330386944,"floatMarketCap":60759901248},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1606\",,,,,undefined,":{"symbol":"BK1606","high":864.6631,"amplitude":0.015535,"preClose":859.2869,"low":851.3144,"pbRate":"0.863325","latestPrice":859.5988,"volume":50071504,"delay":0,"open":855.5556,"prevYearClose":830.6915,"prevWeekClose":860.202,"prevMonthClose":810.955,"prevQuarterClose":810.955,"fiveDayClose":858.884,"twentyDayClose":840.647,"sixtyDayClose":886.776,"secType":"PLATE","market":"HK","turnoverRate":0.003165,"peRate":14.021183,"marketCap":87330386944,"floatMarketCap":60759901248,"timestamp":1776326890394,"nameCN":"中醫藥概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1606\",,,,undefined,":{"bkCode":"BK1606","up":8,"down":2,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1606\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2624947663","title":"白雲山:公司已聘請第三方機構探索制定薪酬績效優化方案","url":"https://stock-news.laohu8.com/highlight/detail?id=2624947663","media":"证券日报","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624947663?lang=zh_tw&edition=fundamental","pubTime":"2026-04-03 22:19","pubTimestamp":1775225940,"startTime":"0","endTime":"0","summary":"证券日报网4月3日讯,白云山在接受调研者提问时表示,公司已聘请第三方机构,结合公司实际发展需求,探索制定薪酬绩效优化方案,进一步激发人才动力,加强人才队伍建设;同时,积极探索适合公司或下属企业发展的改革方案,探索开展混改、职业经理人机制等创新性举措,同时支持符合条件的下属企业探索开展股权激励、员工持股等,进一步激发下属子公司发展活力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604033695294621.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0096","BK0188","BK0028","600332","BK0239","BK1515","BK1521","BK0196","00874","BK0012","BK0175","BK1606","BK1197","BK0097","BK0070","BK0183","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624922663","title":"白雲山:未來五年公司將堅持現代化、科技化、數字化、國際化發展方向","url":"https://stock-news.laohu8.com/highlight/detail?id=2624922663","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624922663?lang=zh_tw&edition=fundamental","pubTime":"2026-04-03 22:19","pubTimestamp":1775225940,"startTime":"0","endTime":"0","summary":"证券日报网4月3日讯,白云山在接受调研者提问时表示,未来五年,公司将坚持现代化、科技化、数字化、国际化发展方向,在推动现代中药、化药科技、天然饮品、医药商业四大基石业务板块提质增效的同时,积蓄动能,培育促进消费健康、生物创新、医疗服务等业务发展,推动公司实现高质量发展。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604033695291745.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["00874","BK0175","BK1521","BK0097","BK1515","600332","BK1197","BK0183","BK1191","BK0070","BK0096","BK0196","BK1606","BK0239","BK0028","BK0188","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624853574","title":"中國中藥(00570)出現大手賣出110萬股,成交價$1.8,涉資198萬","url":"https://stock-news.laohu8.com/highlight/detail?id=2624853574","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624853574?lang=zh_tw&edition=fundamental","pubTime":"2026-04-02 16:08","pubTimestamp":1775117280,"startTime":"0","endTime":"0","summary":"[大手成交]中国中药(00570)在下午04:08出现大手卖出,成交量为110万,成交价为港币$1.8,涉资198万。至目前为止,股价跌0.552%,今日最高价为$1.82,而最低价为$1.79,总成交量为1.74千万股,总成交金额港币$3.143千万。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205145555799_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205145555799_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAV2604024449/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAV2604024449/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1515","00570","BK1606","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624748175","title":"綠葉製藥(02186)出現大手賣出130萬股,成交價$2.92,涉資379.6萬","url":"https://stock-news.laohu8.com/highlight/detail?id=2624748175","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624748175?lang=zh_tw&edition=fundamental","pubTime":"2026-04-02 16:08","pubTimestamp":1775117280,"startTime":"0","endTime":"0","summary":"[大手成交]绿叶制药(02186)在下午04:08出现大手卖出,成交量为130万,成交价为港币$2.92,涉资379.6万。至目前为止,股价升7.749%,今日最高价为$2.98,而最低价为$2.66,总成交量为1.709亿股,总成交金额港币$4.881亿。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180815142908927_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180815142908927_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAV2604024480/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAV2604024480/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02186","BK1606","BK1191","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624597874","title":"白雲山(00874):白雲山製藥總廠獲國家藥監局核准簽發關於骨化三醇軟膠囊的《藥品補充申請批准通知書》","url":"https://stock-news.laohu8.com/highlight/detail?id=2624597874","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624597874?lang=zh_tw&edition=fundamental","pubTime":"2026-04-01 18:48","pubTimestamp":1775040531,"startTime":"0","endTime":"0","summary":"2026年2月5日,白云山制药总厂向国家药监局递交药品上市持有人变更申请,于2026年3月4日获得受理。本次获得骨化三醇软胶囊的《药品补充申请批准通知书》,扩充了白云山制药总厂产品布局,有利于增强本公司在内分泌治疗药物市场的竞争优势。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1424098.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0096","BK1197","BK0188","BK0175","BK0239","BK1574","01477","BK0028","600332","BK0097","BK0012","BK1521","BK0070","BK0196","BK1606","BK1191","BK1515","00874","BK0183"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":25,"code":"91000000","status":"200"}]}}